These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
20 related articles for article (PubMed ID: 3927499)
1. [Characteristics of the course of pulmonary hypertension in patients with chronic obstructive bronchitis (2)]. Kokosov AN; Neklasov IuF; Matkovskiĭ SK; Kachan LV; Aleksandrov AL Ter Arkh; 1988; 60(12):124-7. PubMed ID: 3150133 [TBL] [Abstract][Full Text] [Related]
2. Action of Nitroglycerin and amyl nitrite in labile and essential hypertension: hemodynamic differences. Chrysant SG; Dunn FG; De Carvalho JG; Adamopoulos PN; Frolich ED Arch Intern Med; 1977 Dec; 137(12):1702-5. PubMed ID: 412475 [TBL] [Abstract][Full Text] [Related]
3. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis]. Domenighetti G Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009 [TBL] [Abstract][Full Text] [Related]
4. [Vasodilator therapy in pulmonary hypertension and chronic obstructive lung disease (COPD). Hemodynamic studies exemplified by nifedipine and nitroglycerin]. Gassner A; Fridrich L; Magometschnigg D; Sommer G; Klicpera M Herz; 1986 Aug; 11(4):207-16. PubMed ID: 3093345 [TBL] [Abstract][Full Text] [Related]
5. The effect of low-dose intravenous nitroglycerin on pulmonary hypertension immediately after replacement of a stenotic mitral valve. Ziskind Z; Pohoryles L; Mohr R; Smolinsky A; Quang HT; Ruvolo G; Goor DA Circulation; 1985 Sep; 72(3 Pt 2):II164-9. PubMed ID: 3928188 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular performance in chronic obstructive pulmonary diseases. Matthay RA; Berger HJ Med Clin North Am; 1981 May; 65(3):489-524. PubMed ID: 7017301 [No Abstract] [Full Text] [Related]
7. [Effect of nitroglycerin on various indicators of hemodynamics in patients with chronic obstructive bronchitis complicated by pulmonary hypertension]. Aleksandrov AL; Matkovskii SK; Cherniakova TG Ter Arkh; 1985; 57(5):45-7. PubMed ID: 3927499 [TBL] [Abstract][Full Text] [Related]
8. Haemodynamic requirements for an ideal pulmonary vasodilator. Widimský J; Morpurgo M; Jezek V Eur Heart J; 1988 Sep; 9 Suppl J():23-8. PubMed ID: 3053181 [TBL] [Abstract][Full Text] [Related]
9. Nitroglycerin therapy in the management of pulmonary hypertensive disorders. Packer M; Halperin JL; Brooks KM; Rothlauf EB; Lee WH Am J Med; 1984 Jun; 76(6A):67-75. PubMed ID: 6430080 [TBL] [Abstract][Full Text] [Related]